FIG. 5.
Loss of p53 improves growth of Cdk2−/− Cdk4−/− cells. (A) 3T3 assay performed for 16 passages using WT, Cdk2−/− Cdk4−/−, Cdk2−/− Cdk4−/− p53−/−, Cdk2−/− Cdk4−/− p53+/−, and p53−/− MEFs. The x axis shows the number of passages, and the y axis indicates the cumulative cell number for each passage. (B) Western blot (WB) analysis. One hundred micrograms of protein lysate from passage 3 MEFs of WT (lane 1), Cdk2−/− Cdk4−/− (lane 2), Cdk2−/− Cdk4−/− p53−/− (lane 3), and p53−/− (lane 4) genotypes was separated on a 12.5% gel, and proteins were transferred to a polyvinylidene difluoride membrane. Antibodies against Hsp90, Cdk2, Cdk4, p53, p21, and p27 were used for detection. (C to F) β-Galactosidase staining. Shown are representative images from WT (C), Cdk2−/− Cdk4−/− (D), p53−/− (E), and Cdk2−/− Cdk4−/− p53−/− (F) MEFs stained with β-galactosidase as a marker for senescence. (G) Graph depicting the percentage of proliferating cells and senescent cells at passage 3 in WT, Cdk2−/− Cdk4−/−, Cdk2−/− Cdk4−/− p53−/−, and p53−/− MEFs, counting at least 200 cells for each genotype.